Drugs / Autologous adipose-derived cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04164485 Background | Jul 2019 → Dec 2022 | laryngeal disorder | Chinese Academy of Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous adipose-derived cells | “Autologous adipose-derived cells will be injected into the submucosa of vocal cord and paraglottic space under the surgical microscope” NCT04164485 ↗ |
| Modality | Cell therapy | “Autologous adipose-derived cells” NCT04164485 ↗ |
| Route | Other | “will be injected into the submucosa of vocal cord and paraglottic space” NCT04164485 ↗ |